SAROJA — Saroja Pharma Industries India Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹132.68m
- IN₹273.44m
- IN₹701.29m
Annual cashflow statement for Saroja Pharma Industries India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 15.8 | 14.9 | 12.1 | 14.5 | 22.3 |
| Depreciation | |||||
| Non-Cash Items | 7.91 | 13.1 | 14.2 | 13.7 | 14.3 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -60.9 | -6.71 | -17 | -17.9 | 36.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -36.7 | 21.9 | 10.2 | 11.5 | 74.4 |
| Capital Expenditures | -3.08 | -47.3 | -47.3 | -25.9 | -117 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.269 | -0.898 | -0.331 | -1.06 | 0.446 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.35 | -48.2 | -47.6 | -27 | -117 |
| Financing Cash Flow Items | -8.01 | -13.2 | 70.6 | -21.6 | -7.13 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 42.7 | 27.3 | 37 | 15.6 | 42.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.6 | 0.995 | -0.423 | 0.103 | 0.066 |